181 related articles for article (PubMed ID: 37476993)
21. rs5848 polymorphism and serum progranulin level.
Hsiung GY; Fok A; Feldman HH; Rademakers R; Mackenzie IR
J Neurol Sci; 2011 Jan; 300(1-2):28-32. PubMed ID: 21047645
[TBL] [Abstract][Full Text] [Related]
22. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.
Sellami L; Rucheton B; Ben Younes I; Camuzat A; Saracino D; Rinaldi D; Epelbaum S; Azuar C; Levy R; Auriacombe S; Hannequin D; Pariente J; Barbier M; Boutoleau-Bretonnière C; Couratier P; Pasquier F; Deramecourt V; Sauvée M; Sarazin M; Lagarde J; Roué-Jagot C; Forlani S; Jornea L; David I; ; ; LeGuern E; Dubois B; Brice A; Clot F; Lamari F; Le Ber I
Neurobiol Aging; 2020 Jul; 91():167.e1-167.e9. PubMed ID: 32171590
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
[TBL] [Abstract][Full Text] [Related]
24. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.
Ljubenkov PA; Edwards L; Iaccarino L; La Joie R; Rojas JC; Koestler M; Harris B; Boeve BF; Borroni B; van Swieten JC; Grossman M; Pasquier F; Frisoni GB; Mummery CJ; Vandenberghe R; Le Ber I; Hannequin D; McGinnis SM; Auriacombe S; Onofrj M; Goodman IJ; Riordan HJ; Wisniewski G; Hesterman J; Marek K; Haynes BA; Patzke H; Koenig G; Hilt D; Moebius H; Boxer AL
JAMA Netw Open; 2021 Sep; 4(9):e2125584. PubMed ID: 34559230
[TBL] [Abstract][Full Text] [Related]
25. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; Padovani A; Tagliavini F; Masellis M; Tartaglia MC; van Swieten J; Meeter L; Graff C; de Mendonça A; Bocchetta M; Rohrer JD; Scarpini E;
Neurobiol Aging; 2018 Feb; 62():245.e9-245.e12. PubMed ID: 29146050
[TBL] [Abstract][Full Text] [Related]
26. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation.
Alberici A; Archetti S; Pilotto A; Premi E; Cosseddu M; Bianchetti A; Semeraro F; Salvetti M; Muiesan ML; Padovani A; Borroni B
Neurol Sci; 2014 Aug; 35(8):1215-9. PubMed ID: 24569924
[TBL] [Abstract][Full Text] [Related]
27. Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.
Willemse EA; Durieux-Lu S; van der Flier WM; Pijnenburg YA; de Jonge R; Teunissen CE
J Alzheimers Dis; 2016 Apr; 53(1):107-16. PubMed ID: 27104901
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation.
Bruni AC; Momeni P; Bernardi L; Tomaino C; Frangipane F; Elder J; Kawarai T; Sato C; Pradella S; Wakutani Y; Anfossi M; Gallo M; Geracitano S; Costanzo A; Smirne N; Curcio SA; Mirabelli M; Puccio G; Colao R; Maletta RG; Kertesz A; St George-Hyslop P; Hardy J; Rogaeva E
Neurology; 2007 Jul; 69(2):140-7. PubMed ID: 17620546
[TBL] [Abstract][Full Text] [Related]
29. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients.
Almeida S; Gao F; Coppola G; Gao FB
Neurobiol Aging; 2016 Jun; 42():35-40. PubMed ID: 27143419
[TBL] [Abstract][Full Text] [Related]
30. The missense p.Trp7Arg mutation in GRN gene leads to progranulin haploinsufficiency.
Saracino D; Sellami L; Clot F; Camuzat A; Lamari F; Rucheton B; Benyounes I; Roué-Jagot C; Lagarde J; Sarazin M; Jornea L; Forlani S; LeGuern E; Dubois B; Brice A; Le Ber I
Neurobiol Aging; 2020 Jan; 85():154.e9-154.e11. PubMed ID: 31262553
[TBL] [Abstract][Full Text] [Related]
31. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
32. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.
Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D
Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611
[TBL] [Abstract][Full Text] [Related]
33. Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation.
Aggarwal G; Banerjee S; Jones SA; Benchaar Y; Bélanger J; Sévigny M; Smith DM; Niehoff ML; Pavlack M; de Vera IMS; Petkau TL; Leavitt BR; Ling K; Jafar-Nejad P; Rigo F; Morley JE; Farr SA; Dutchak PA; Sephton CF; Nguyen AD
J Biol Chem; 2023 Dec; 299(12):105475. PubMed ID: 37981208
[TBL] [Abstract][Full Text] [Related]
34. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
Kim EJ; Kwon JC; Park KH; Park KW; Lee JH; Choi SH; Jeong JH; Kim BC; Yoon SJ; Yoon YC; Kim S; Park KC; Choi BO; Na DL; Ki CS; Kim SH
Neurobiol Aging; 2014 May; 35(5):1213.e13-7. PubMed ID: 24387985
[TBL] [Abstract][Full Text] [Related]
36. Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.
Lee WC; Almeida S; Prudencio M; Caulfield TR; Zhang YJ; Tay WM; Bauer PO; Chew J; Sasaguri H; Jansen-West KR; Gendron TF; Stetler CT; Finch N; Mackenzie IR; Rademakers R; Gao FB; Petrucelli L
Hum Mol Genet; 2014 Mar; 23(6):1467-78. PubMed ID: 24163244
[TBL] [Abstract][Full Text] [Related]
37. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
Suárez-Calvet M; Dols-Icardo O; Lladó A; Sánchez-Valle R; Hernández I; Amer G; Antón-Aguirre S; Alcolea D; Fortea J; Ferrer I; van der Zee J; Dillen L; Van Broeckhoven C; Molinuevo JL; Blesa R; Clarimón J; Lleó A
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):684-91. PubMed ID: 24309270
[TBL] [Abstract][Full Text] [Related]
38. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
[TBL] [Abstract][Full Text] [Related]
39. Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.
Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Wang G; Guo QH
Curr Alzheimer Res; 2017; 14(10):1102-1108. PubMed ID: 28462717
[TBL] [Abstract][Full Text] [Related]
40. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study.
Ghidoni R; Stoppani E; Rossi G; Piccoli E; Albertini V; Paterlini A; Glionna M; Pegoiani E; Agnati LF; Fenoglio C; Scarpini E; Galimberti D; Morbin M; Tagliavini F; Binetti G; Benussi L
Neurodegener Dis; 2012; 9(3):121-7. PubMed ID: 22123177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
